Status:
UNKNOWN
Maxillary Molar Distalization Supported by Mini-implants With the Advanced Molar Distalization Appliance (Amda®)
Lead Sponsor:
Grigore T. Popa University of Medicine and Pharmacy
Collaborating Sponsors:
Aristotle University Of Thessaloniki
Conditions:
Angle Class II
Eligibility:
All Genders
14-20 years
Phase:
NA
Brief Summary
The aim of this randomized controlled clinical trial is to evaluate the dentoalveolar and skeletal treatment effects of the AMDA when used for distalization of the maxillary first molars in patients w...
Detailed Description
The primary aim is to evaluate two different treatment groups from initiation of treatment up until completion of maxillary molar distalization of: * Group I: patients treated with amda® * Group II: ...
Eligibility Criteria
Inclusion
- All patients to have permanent dentition
- with or without the 2nd molar erupted
- bilateral Class II molar relationships (a quarter to 1 molar cusp).
Exclusion
- Past orthodontic treatment
- crossbites,
- severe carious lesions,
- poor oral hygiene,
- mobility of the maxillary first molars,
- anterior open bites,
- vertical growth pattern,
- tongue habits.
Key Trial Info
Start Date :
June 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 20 2025
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06011382
Start Date
June 20 2022
End Date
June 20 2025
Last Update
August 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Medicine and Pharmacy "Grigore T. Popa"
Iași, Romania, 70015